About this data
What it is
ClinicalTrials.gov is the US registry of clinical studies. Drug and device makers register their trials there and update the record as each study moves on. We list the studies that companies sponsor, and match the sponsor to a public company when the name lines up. The page opens on Phase 3 studies marked completed, the late-stage trials that come before a request for approval. Change View to see the changes of status we have noticed, or every recent update.
Who files it
The sponsor of the study, in its record on ClinicalTrials.gov. The registry is run by the US National Library of Medicine and does not check what sponsors report.
How current
We check the registry every day. Sponsors update records on their own schedule, from the same week to months later, so a change can appear in the registry well after it happened.
Terms
ClinicalTrials.govClinicalTrials.gov is the US government's registry of clinical studies, run by the National Library of Medicine. Sponsors register a study before it starts and update the record as it goes. The registry does not check what a sponsor reports.Phase 3The late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.statusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).completedThe sponsor has marked the study as finished. It says nothing about whether the treatment worked: results, if any, are reported separately and often later.status changesOur history of status changes starts the day we first stored each study, so a change made before that is not shown. The date is when we noticed the change, which can be later than when the sponsor made it.primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.company matchWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.
Worth knowing
A completed study is not a result: the registry says the study ended, not whether the treatment worked. Status changes start on the day we first stored each study, so earlier changes are not shown. Dates are the sponsor's own, and an estimated date can pass without an update. We match sponsors to companies automatically, with a hand-checked list for the large drugmakers, so a study with no ticker may still belong to a public company. This is information about studies, not a forecast of what they will show or of a stock's price.
Not to be confused with
FDA approvals and clearances: what the FDA decided, not what a sponsor reports about a study.

All of this comes from ClinicalTrials.gov, the US registry of clinical studies. We are not affiliated with it.

Studies updated per day, last 30 days

0200400600Oct 17 · All industry-sponsored studies: 0Oct 17 · Sponsor matched to a public company: 0Oct 17Oct 18 · All industry-sponsored studies: 0Oct 18 · Sponsor matched to a public company: 0Oct 19 · All industry-sponsored studies: 238Oct 19 · Sponsor matched to a public company: 79Oct 20 · All industry-sponsored studies: 278Oct 20 · Sponsor matched to a public company: 92Oct 21 · All industry-sponsored studies: 244Oct 21 · Sponsor matched to a public company: 78Oct 21Oct 22 · All industry-sponsored studies: 234Oct 22 · Sponsor matched to a public company: 67Oct 23 · All industry-sponsored studies: 259Oct 23 · Sponsor matched to a public company: 93Oct 24 · All industry-sponsored studies: 0Oct 24 · Sponsor matched to a public company: 0Oct 25 · All industry-sponsored studies: 0Oct 25 · Sponsor matched to a public company: 0Oct 25Oct 26 · All industry-sponsored studies: 253Oct 26 · Sponsor matched to a public company: 70Oct 27 · All industry-sponsored studies: 283Oct 27 · Sponsor matched to a public company: 102Oct 28 · All industry-sponsored studies: 287Oct 28 · Sponsor matched to a public company: 97Oct 29 · All industry-sponsored studies: 256Oct 29 · Sponsor matched to a public company: 88Oct 29Oct 30 · All industry-sponsored studies: 252Oct 30 · Sponsor matched to a public company: 103Oct 31 · All industry-sponsored studies: 0Oct 31 · Sponsor matched to a public company: 0Nov 1 · All industry-sponsored studies: 0Nov 1 · Sponsor matched to a public company: 0Nov 2 · All industry-sponsored studies: 305Nov 2 · Sponsor matched to a public company: 99Nov 2Nov 3 · All industry-sponsored studies: 478Nov 3 · Sponsor matched to a public company: 257Nov 4 · All industry-sponsored studies: 390Nov 4 · Sponsor matched to a public company: 184Nov 5 · All industry-sponsored studies: 356Nov 5 · Sponsor matched to a public company: 143Nov 6 · All industry-sponsored studies: 338Nov 6 · Sponsor matched to a public company: 135Nov 6Nov 7 · All industry-sponsored studies: 0Nov 7 · Sponsor matched to a public company: 0Nov 8 · All industry-sponsored studies: 0Nov 8 · Sponsor matched to a public company: 0Nov 9 · All industry-sponsored studies: 309Nov 9 · Sponsor matched to a public company: 101Nov 10 · All industry-sponsored studies: 347Nov 10 · Sponsor matched to a public company: 139Nov 10Nov 11 · All industry-sponsored studies: 0Nov 11 · Sponsor matched to a public company: 0Nov 12 · All industry-sponsored studies: 576Nov 12 · Sponsor matched to a public company: 214Nov 13 · All industry-sponsored studies: 329Nov 13 · Sponsor matched to a public company: 136Nov 14 · All industry-sponsored studies: 0Nov 14 · Sponsor matched to a public company: 0Nov 14Nov 15 · All industry-sponsored studies: 0Nov 15 · Sponsor matched to a public company: 0
0200400600Oct 17 · All industry-sponsored studies: 0Oct 17 · Sponsor matched to a public company: 0Oct 17Oct 18 · All industry-sponsored studies: 0Oct 18 · Sponsor matched to a public company: 0Oct 19 · All industry-sponsored studies: 238Oct 19 · Sponsor matched to a public company: 79Oct 20 · All industry-sponsored studies: 278Oct 20 · Sponsor matched to a public company: 92Oct 21 · All industry-sponsored studies: 244Oct 21 · Sponsor matched to a public company: 78Oct 21Oct 22 · All industry-sponsored studies: 234Oct 22 · Sponsor matched to a public company: 67Oct 23 · All industry-sponsored studies: 259Oct 23 · Sponsor matched to a public company: 93Oct 24 · All industry-sponsored studies: 0Oct 24 · Sponsor matched to a public company: 0Oct 25 · All industry-sponsored studies: 0Oct 25 · Sponsor matched to a public company: 0Oct 25Oct 26 · All industry-sponsored studies: 253Oct 26 · Sponsor matched to a public company: 70Oct 27 · All industry-sponsored studies: 283Oct 27 · Sponsor matched to a public company: 102Oct 28 · All industry-sponsored studies: 287Oct 28 · Sponsor matched to a public company: 97Oct 29 · All industry-sponsored studies: 256Oct 29 · Sponsor matched to a public company: 88Oct 29Oct 30 · All industry-sponsored studies: 252Oct 30 · Sponsor matched to a public company: 103Oct 31 · All industry-sponsored studies: 0Oct 31 · Sponsor matched to a public company: 0Nov 1 · All industry-sponsored studies: 0Nov 1 · Sponsor matched to a public company: 0Nov 2 · All industry-sponsored studies: 305Nov 2 · Sponsor matched to a public company: 99Nov 2Nov 3 · All industry-sponsored studies: 478Nov 3 · Sponsor matched to a public company: 257Nov 4 · All industry-sponsored studies: 390Nov 4 · Sponsor matched to a public company: 184Nov 5 · All industry-sponsored studies: 356Nov 5 · Sponsor matched to a public company: 143Nov 6 · All industry-sponsored studies: 338Nov 6 · Sponsor matched to a public company: 135Nov 6Nov 7 · All industry-sponsored studies: 0Nov 7 · Sponsor matched to a public company: 0Nov 8 · All industry-sponsored studies: 0Nov 8 · Sponsor matched to a public company: 0Nov 9 · All industry-sponsored studies: 309Nov 9 · Sponsor matched to a public company: 101Nov 10 · All industry-sponsored studies: 347Nov 10 · Sponsor matched to a public company: 139Nov 10Nov 11 · All industry-sponsored studies: 0Nov 11 · Sponsor matched to a public company: 0Nov 12 · All industry-sponsored studies: 576Nov 12 · Sponsor matched to a public company: 214Nov 13 · All industry-sponsored studies: 329Nov 13 · Sponsor matched to a public company: 136Nov 14 · All industry-sponsored studies: 0Nov 14 · Sponsor matched to a public company: 0Nov 14Nov 15 · All industry-sponsored studies: 0Nov 15 · Sponsor matched to a public company: 0

All industry-sponsored studies Sponsor matched to a public company

By the day the sponsor last updated the study's record. A study updated twice counts once, on its latest day.

Latest clinical trial updates

Reset

Showing: ticker LIVN · All recent updates

Studies by the date their record was last updated.

Latest clinical trial updates
UpdatedStudySponsorWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.PhaseThe late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.StatusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).EnrolledPrimary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.Source
Nov 4, 2026A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effec…
NCT03887715 · Treatment Resistant Depression
Vagus Nerve Stimulation (VNS)
LIVN
LivaNova
Not applicableRecruiting6,800Feb 28, 2028Registry ↗
Aug 27, 2026A Study to Assess Effectiveness and Efficiency of VNS Therapy in Patients With Difficult to Treat D…
NCT03320304 · Treatment Resistant Depression
Vagal Nerve Simulation (VNS) Therapy
LIVN
LivaNova
—Recruiting500Dec 1, 2029Registry ↗
Jul 17, 2026Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation
NCT04950894 · Obstructive Sleep Apnea, OSA
Hypoglossal Nerve Stimulation
LIVN
LivaNova
Not applicableCompleted107Oct 17, 2024Registry ↗
Mar 25, 2026Non-interventional Study Describing Healthcare Resource Utilisation and Clinical Outcomes Associate…
NCT04779814 · Epilepsy
LIVN
LivaNova
—Terminated97Aug 19, 2025Registry ↗
Dec 20, 2024The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will p…
NCT04753385 · Treatment Resistant Depression
LIVN
LivaNova
—Terminated138Sep 6, 2024Registry ↗
Dec 3, 2024IMPACT of AspireSR® for VNS Therapy on Healthcare Resource Utilisation and Clinical Outcomes.
NCT05975931 · Epilepsy
LIVN
LivaNova
—Terminated15Jan 30, 2024Registry ↗
Nov 22, 2024Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.
NCT03529045 · Epilepsy, Seizures
Vagus Nerve Stimulation (VNS) Therapy
LIVN
LivaNova
—Completed827Sep 11, 2024Registry ↗
Oct 10, 2023ANTHEM-HFrEF Pivotal Study
NCT03425422 · Heart Failure, Heart Failure, Congestive
VITARIA System
LIVN
LivaNova
Not applicableTerminated533May 31, 2023Registry ↗
Oct 25, 2022Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study
NCT03446664 · Epilepsies, Partial, Epilepsy, Tonic-Clonic
Microburst Stimulation
LIVN
LivaNova
Not applicableCompleted33Jul 30, 2021Registry ↗
Aug 25, 2020XLTCS - Accelerometer Data Collection in an Epilepsy Monitoring Unit (EMU)
NCT04282681 · Epilepsy, Tonic-Clonic
Accelerometer Live-Streaming Tool
LIVN
LivaNova
—Withdrawn0Aug 28, 2021Registry ↗
Feb 20, 2020Mitroflow DL Post Approval Study- North America
NCT02351726 · Aortic Stenosis, Aortic Regurgitation
Mitroflow DL
LIVN
LivaNova
Not applicableTerminated186Dec 31, 2019Registry ↗
May 28, 2019Clinical Evaluation of LEft VEntricular Auto Threshold Algorithm (LEVEA)
NCT03014180 · Heart Failure
"In-Clinic LVAT"
LIVN
LivaNova
Not applicableCompleted60Aug 17, 2017Registry ↗
Mar 13, 2018VAgal Nerve Stimulation: safeGUARDing Heart Failure Patients
NCT02113033 · Heart Failure With Reduced Ejection Fraction
Equilia® Vagal Nerve Stimulation
LIVN
LivaNova
Phase 2Completed15Feb 22, 2016Registry ↗
Mar 13, 2018Clinical Evaluation Of The Nano Lv Lead System In Chronic Situation (LENEA)
NCT01731210 · LV Lead, LV Therapy
implantation of the new LV lead: NANO system.
LIVN
LivaNova
Phase 2/3Terminated9—Registry ↗
Nov 14, 2017Sleep Apnea, Arrhythmias and Cardiac Reverse Remodeling in Heart Failure Patients
NCT02870647 · Sleep Breathing Disorders in the Responders to Cardiac Resy…
Echocardiographic, polygraphy, electrocardiography measurem…
LIVN
LivaNova
Phase 4Withdrawn0Jun 2019Registry ↗
Nov 14, 2017Optimization With SonR Method in the ClinicAl pRactice
NCT02250547 · CRT Patients
LIVN
LivaNova
—Completed278Jan 2017Registry ↗
Nov 14, 2017Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers
NCT00531037 · Patients Implanted With a Pacemaker
LIVN
LivaNova
—Completed1,440Dec 2011Registry ↗
Oct 18, 2017Evolution of the PR Interval in Patients Implanted With a Pacemaker Using the SafeR Mode
NCT02586480 · Sinus Node Dysfunction, Atrioventricular Block
dual chamber pacemaker with SafeR algorithm
LIVN
LivaNova
—Completed848Nov 2015Registry ↗
Oct 5, 2017PErsonalized and Adaptive Kinesthetic stImulation Therapy, Based on Cardio-respiratory Holter moNit…
NCT02789748 · Obstructive Sleep Apnea Syndrome
Kinesthetic stimulation
LIVN
LivaNova
Not applicableCompleted42Oct 2, 2017Registry ↗
Oct 3, 2017HYpopnea and Apnea Detection and Treatment Performance of a New cardiOreSpiratory Holter Monitor
NCT03300037 · Sleep Apnea, Obstructive
Kinesthetic stimulation
LIVN
LivaNova
—Completed46Apr 16, 2015Registry ↗
Apr 25, 2017Left Ventricular Pacing Vectors Effectiveness to Narrow Phrenic Nerve Stimulation
NCT03127202 · Heart Failure
Cardiac Resynchronization Therapy -Defibrillator (range PAR…
LIVN
LivaNova
Not applicableCompleted90Dec 2015Registry ↗
Apr 6, 2017The remedē® System for the Treatment of Central Sleep Apnea in Daily Practice
NCT02577445 · Sleep Apnea, Central Sleep Disordered Breathing
LIVN
LivaNova
—Terminated31Oct 2016Registry ↗
Dec 3, 2015Impact of Ventricular Pacing in Unselected ICD/CRT-D Patients
NCT01169896 · Ventricular Tachycardia, Ventricular Fibrillation
LIVN
LivaNova
—Completed616Dec 2011Registry ↗
Jan 13, 2015Optimal Anti-tachycardia Therapy in Implantable Cardioverter-defibrillator (ICD) Patients Without P…
NCT00729703 · Tachycardia
Ovatio DR 6550, OVATIO DR 6550
LIVN
LivaNova
Phase 4Completed462Dec 2011Registry ↗
Jan 12, 2015Clinical Status Monitoring in Implantable Cardiac Defibrillator (ICD) Patients by Physiological Dia…
NCT01170624 · Heart Failure
ICD
LIVN
LivaNova
Phase 4Terminated388Sep 2011Registry ↗
Jan 12, 2015Predictive Risk Stratification Through T Variability in ICD Patients Without Pacing Indications
NCT00560768 · Sudden Cardiac Death
Ovatio VR 6250 or DR6550
LIVN
LivaNova
Phase 4Completed198Aug 2012Registry ↗

26 items, most recent first (up to 50). Each row links to the study's page on ClinicalTrials.gov. Updated Nov 15, 2026, 7:10 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · FDA approvals and clearances